CD274 and melanoma: We examined the in vivo efficacy of the anti-PD-L1 VHH (A12)-VHHkappa conjugate using the MC38 mouse colon carcinoma and B16-F10 melanoma models (Fig. 5A and 5B), with the experimental setup described earlier.